Coupled together, these results and our outcomes suggest that mRNA expression levels of SLC7A1 may serve as both a tissue and blood biomarker of hypertension in workers exposed to MWCNTs and may be particularly useful in workers with preexisting cardiovascular disease. Here, SLC7A1 is linked to hypertensive disorder.